Filtered By:
Management: Food and Drug Administration (FDA)
Countries: Italy Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 17 results found since Jan 2013.
Sensitivity of three commercial tests for SARS-CoV-2 serology in children: an Italian multicentre prospective study
US Food and Drug Administration has issued Emergency Use Authorizations for hundreds of serological assays to support Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) diagnosis. The aim of this stu...
Source: Italian Journal of Pediatrics - December 2, 2022 Category: Pediatrics Authors: Elisabetta Venturini, Sabrina Giometto, Agnese Tamborino, Laura Becciolini, Samantha Bosis, Giovanni Corsello, Paolo Del Barba, Silvia Garazzino, Andrea Lo Vecchio, Alessandra Pugi, Sara Signa, Giacomo Stera, Sandra Trapani, Guido Castelli Gattinara, Ersi Tags: Research Source Type: research
Why Countries Around the World Are Suspending Use of AstraZeneca ’s COVID-19 Vaccine
It’s the last thing public health officials want to see in the midst of a pandemic: more than two months after pharmaceutical giant AstraZeneca and Oxford University scientists released their COVID-19 vaccine, countries in Europe and elsewhere are pausing its use amid disconcerting reports that a small number of recipients have experienced blood clots, some of them fatal.
The European Medicines Agency, which oversees drugs and vaccines in Europe, is expected to issue a guidance on March 18 about whether the side effects were related to the vaccine after reviewing the reports; in the meantime, it says the benefits of ...
Source: TIME: Health - March 16, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
The U.S. COVID-19 Outbreak Is Worse Than It ’s Ever Been. Why Aren’t We Acting Like It?
Nothing about the current COVID-19 explosion should come as a surprise. As the virus spread throughout summer and fall, experts repeatedly warned winter would be worse.
They cautioned that a cold-weather return to indoor socializing, particularly around the holidays, could turn a steady burn into a wildfire. Throw in a lame-duck President, wildly differing approaches by the states and a pervasive sense of quarantine fatigue, and the wildfire could easily become an inferno.
So it has. The U.S. is now locked in a deadly cycle of setting, then shattering, records for new cases and hospitalizations. On Nov. 13, a staggering 17...
Source: TIME: Health - November 19, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cover Story COVID-19 feature Magazine Source Type: news
At 74, President Trump Is at Higher Risk of COVID-19 Complications
The news that U.S. President Donald Trump and First Lady Melania Trump have tested positive for COVID-19 is a reminder of two stark truths that we’ve known since the first days that the novel coronavirus reached the United States: that the virus respects no boundaries, and that older people are at higher risk of getting infected.
About 10 months into the pandemic, the science shows that the elderly not only remain more vulnerable to infections but are also more likely to develop severe illness. About 80% of deaths in the U.S. from COVID-19 have occurred in those 65 or older, according to the U.S. Centers for Disease ...
Source: TIME: Health - October 2, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Explainer overnight Source Type: news
Covid-19 Deaths: 1 Million and Surging
Face masks hanging on window bars in Havana, Cuba. Credit: Jorge Luis Baños/IPS By Joseph ChamieNEW YORK, Oct 1 2020 (IPS) Covid-19 deaths worldwide have surpassed 1 million. With new cases of coronavirus infections rapidly mounting again, the numbers of Covid-19 deaths are feared to surge in the coming months.
It took approximately 40 weeks to reach the first million Covid-19 recorded deaths. Some have projected the second million Covid-19 deaths to take about 10 weeks, arriving in late December, and the third million to take an additional 4 weeks, arriving in late January.
Approximately 60 percent of the 1 million Cov...
Source: IPS Inter Press Service - Health - October 1, 2020 Category: International Medicine & Public Health Authors: Joseph Chamie Tags: Global Headlines Health TerraViva United Nations COVID-19 Source Type: news
The Great Vaccine Race: Inside the Unprecedented Scramble to Immunize the World Against COVID-19
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins.
Such was the case with SARS-CoV-2, the coronavirus behind COVID-19, and the attack was mostly silent and insidious at first. Many people infected with SARS-CoV-2 remained oblivious as they served as the v...
Source: TIME: Health - September 10, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Magazine Source Type: news
COVID-19 Has Killed Nearly 200,000 Americans. How Many More Lives Will Be Lost Before the U.S. Gets It Right?
Forty-five days before the announcement of the first suspected case of what would become known as COVID-19, the Global Health Security Index was published. The project—led by the Nuclear Threat Initiative and the Johns Hopkins Center for Health Security—assessed 195 countries on their perceived ability to handle a major disease outbreak. The U.S. ranked first.
It’s clear the report was wildly overconfident in the U.S., failing to account for social ills that had accumulated in the country over the past few years, rendering it unprepared for what was about to hit. At some point in mid-September—perha...
Source: TIME: Health - September 10, 2020 Category: Consumer Health News Authors: Alex Fitzpatrick and Elijah Wolfson Tags: Uncategorized Cover Story COVID-19 feature Magazine Source Type: news
Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic Virology
Laboratories are currently witnessing extraordinary demand globally for sampling devices, reagents, consumables, and diagnostic instruments needed for timely diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. To meet diagnostic needs as the pandemic grows, the U.S. Food and Drug Administration (FDA) recently granted several commercial SARS-CoV-2 tests Emergency Use Authorization (EUA), but manufacturer-independent evaluation data are scarce. We performed the first manufacturer-independent evaluation of the fully automated sample-to-result two-target test cobas 6800 SARS-CoV-2 (cobas) (Roch...
Source: Journal of Clinical Microbiology - May 25, 2020 Category: Microbiology Authors: Poljak, M., Korva, M., Knap Gasper, N., Fujs Komlos, K., Sagadin, M., Ursic, T., Avsic Zupanc, T., Petrovec, M. Tags: Virology Source Type: research
A Top Government Scientist Claims He Was Ousted for Raising Concerns About Malaria Drug Touted by Trump
(WASHINGTON) — The Trump administration failed to prepare for the onslaught of the coronavirus, then sought a quick fix by trying to rush an unproven drug to patients, a senior government scientist alleged in a whistleblower complaint Tuesday.
Dr. Rick Bright, former director of the Biomedical Advanced Research and Development Authority, alleges he was reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug pushed by President Donald Trump. He said the Trump administration wanted to “flood” hot spots in New York and New Jersey with t...
Source: TIME: Health - May 5, 2020 Category: Consumer Health News Authors: RICARDO ALONSO-ZALDIVAR, MICHAEL BALSAMO and COLLEEN LONG / AP Tags: Uncategorized COVID-19 News Desk wire Source Type: news
Trump Says U.S. Will Run 5 Million Daily Virus Tests ‘Very Soon.’ His Testing Chief Says That’s Impossible
President Donald Trump declared Tuesday that the U.S. will be able to carry out five million coronavirus tests per day, but the top official overseeing testing strategy told TIME earlier in the day that goal wasn’t feasible given current technology.
Admiral Brett Giroir, the assistant secretary of health who is in charge of the government’s testing response, said during an interview on Tuesday morning that “there is absolutely no way on Earth, on this planet or any other planet, that we can do 20 million tests a day, or even five million tests a day.”
Since the beginning of the year, the Administrat...
Source: TIME: Health - April 29, 2020 Category: Consumer Health News Authors: W.J. Hennigan Tags: Uncategorized COVID-19 Source Type: news
How Germany Leveraged Digital Health to Combat COVID-19
If you take a look at the number of novel coronavirus cases, you will notice that Germany ranks among the top in terms of most cases. Now, if you take a closer look, you will see that the number of fatal cases in the country is merely a fraction of the total cases. Their mortality rate has been consistently lower than that of those nations sharing a similarly high number of confirmed cases like China, Italy and Spain.
How does Germany manage those numbers? The truth is that even experts aren’t sure. “We don’t know the reason for the lower death rate,” Marieke Degen, deputy spokeswoman of Germany’s Robert Koch ...
Source: The Medical Futurist - April 9, 2020 Category: Information Technology Authors: Prans Tags: Future of Medicine Healthcare Policy digital health coronavirus covid covid19 germany Source Type: blogs
Why Is Germany ’s Coronavirus Death Rate So Low?
With more than 63,000 confirmed cases of COVID-19 as of March 30, Germany is one of the countries worst-affected by the pandemic, according to official statistics.
But only 560 people known to be suffering from the disease caused by the novel coronavirus have died there, putting Germany’s case fatality rate at just 0.9%. That gives Germany one of the lowest rates in the world, making it an outlier compared to places like Italy, where 11.0% of confirmed patients have died from the disease, and even the U.S., which has a rate of 1.8%.
According to experts, Germany’s case fatality rate is so low due to its widesp...
Source: TIME: Health - March 30, 2020 Category: Consumer Health News Authors: Billy Perrigo Tags: Uncategorized COVID-19 Explainer Londontime Source Type: news
The Coronavirus Pandemic Is Creating a Drug Supply Crisis Just When We Most Need Medicine
As the world scrambles for a magic pharmaceutical bullet to stop the coronavirus, drugs perceived as cures – despite reed-thin evidence — have vanished from pharmacy shelves. Just last Friday, after President Trump touted the still unproven remedy of a malaria drug, hydroxychloroquine, the Food and Drug Administration lifted a restriction it had imposed on a Indian drug manufacturer with a record of manipulating its quality data, to allow it to make the active ingredient now suddenly in hot demand. With the United States long dependent on foreign drug manufacturers for low-cost medicine and key drug ingredients...
Source: TIME: Health - March 26, 2020 Category: Consumer Health News Authors: Katherine Eban Tags: Uncategorized COVID-19 Source Type: news
The First U.S. Company Has Announced an Upcoming Home COVID-19 Test
Everlywell, a home testing company that offers dozens of lab tests to consumers, is adding a COVID-19 test beginning on March 23.
Given the slow roll out of testing for COVID-19 in the U.S., and concerns about spreading the disease, at-home testing could help to diagnose more cases. After initially limiting testing to one provided by the Centers for Disease Control and conducted at state and local public health labs, the Food and Drug Administration allowed certified labs, including commercial lab testing companies, to develop and distribute COVID-19 tests on Feb. 29. Though other private companies have been involved with ...
Source: TIME: Health - March 19, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Coronavirus Fears Are Leading to Blood Drive Cancellations at ‘Unprecedented’ Rates in the U.S.
Winter is not a boom time for blood donation centers in the U.S. Bad weather, plus circulating flu strains, tend to deter people from giving blood. And the ongoing outbreak of the new coronavirus in the U.S. has worsened an already lean time. According to the American Red Cross, about 1,500 of their blood drives across the country have been canceled because of concerns about the coronavirus. The organization estimates that they’ve lost out on roughly 46,000 donations as a result. Meanwhile, the demand for blood is still strong.
“We’ve not seen anything like this at the Red Cross,” says Chris Hrouda,...
Source: TIME: Health - March 16, 2020 Category: Consumer Health News Authors: Mandy Oaklander Tags: Uncategorized COVID-19 Source Type: news
